Sotalol Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Sotalol Hydrochloride contains NLT 98.5% and NMT 101.5% of sotalol hydrochloride (C12H30N2O3S · HCl).
2 IDENTIFICATION
A. SPECTROSCOPIC IDENTIFICATION TESTS 〈197〉 , Infrared Spectroscopy: 197K
B. The retention time of the sotalol peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Mobile phase: Transfer about 1.08 g of sodium 1-octanesulfonate to a 1000-mL volumetric flask. Dissolve in 10 mL of glacial acetic acid and about 70 mL of water. Add 720 mL of water and dilute with acetonitrile to volume.
Diluent: Acetonitrile and water (1:4)
Internal standard solution: 4.5 mg/mL of caffeine in Diluent
Standard stock solution: 2 mg/mL of USP Sotalol Hydrochloride RS in Diluent
Standard solution: 0.2 mg/mL of USP Sotalol Hy drochloride RS prepared as follows. Transfer 10.0 mL of Standard stock solution and 5.0 mL of Internal standard solution to a 100-mL volumetric flask. Dilute with Diluent to volume.
Sample stock solution: 2 mg/mL of Sotalol Hydrochloride in Diluent
Sample solution: 0.2 mg/mL of Sotalol Hydrochloride prepared as follows. Transfer 10 mL of Sample stock solution and 5.0 mL of Internal standard solution to a 100-mL volumetric flask. Dilute with Diluent to volume.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 238 nm
Column: 3.9-mm × 30-cm; 10-µm packing L1
Flow rate: 1.5 mL/min
Injection volume: 25 µL
System suitability
Sample: Standard solution
[NOTE—The relative retention times for caffeine and sotalol are 0.39 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 8.5 between caffeine and sotalol Relative standard deviation: NMT 0.55%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of sotalol hydrochloride (C12H30N2O3S · HCl) in the portion of Sotalol Hydrochloride taken:
Result = (RU/RS) × (CS/CU) × 100
RU = peak area ratio of sotalol to caffeine from the Sample solution
RS = peak area ratio of sotalol to caffeine from the Standard solution
CS = concentration of USP Sotalol Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Sotalol Hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 98.5%–101.5%
4 IMPURITIES
RESIDUE ON IGNITION 〈281〉: NMT 0.5%
ORGANIC IMPURITIES
Mobile phase and Chromatographic system: Proceed as directed in the Assay.
Standard solution: 6 µg/mL each of USP Sotalol Hydrochloride RS, USP Sotalol Related Compound A RS, USP Sotalol Related Compound B RS, and USP Sotalol Related Compound C RS in Mobile phase
Sample solution: 2 mg/mL of Sotalol Hydrochloride in Mobile phase
System suitability
Sample: Standard solution
[NOTE—See Table 1 for relative retention times.]
Suitability requirements
Resolution: NLT 2.0 between sotalol related compound A and sotalol Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each sotalol related compound in the portion of Sotalol Hydrochloride taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of the corresponding sotalol related compound from the Sample solution
rS = peak response of the corresponding sotalol related compound from the Standard solution
CS = concentration of the corresponding Reference Standard in the Standard solution (µg/mL)
CU = concentration of Sotalol Hydrochloride in the Sample solution (µg/mL)
Calculate the percentage of any unspecified impurity in the portion of Sotalol Hydrochloride taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each unspecified impurity from the Sample solution
rS = peak response of sotalol from the Standard solution
CS = concentration of USP Sotalol Hydrochloride RS in the Standard solution (µg/mL)
CU = concentration of Sotalol Hydrochloride in the Sample solution (µg/mL)
Acceptance criteria: See Table 1.
Table 1
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Sotalol related compound B | 0.65 | 0.3 |
| Sotalol | 1.0 | — |
| Sotalol related compound A | 1.2 | 0.3 |
| Sotalol related compound C | 1.4 | 0.4 |
| Any unspecified impurity | — | 0.10 |
| Total impurities | — | 0.5 |
5 SPECIFIC TESTS
CONTENT OF CHLORIDE
Sample: 310 mg
Titrimetric system
Mode: Direct titration
Titrant: 0.1 N silver nitrate VS Endpoint detection: Potentiometric
Analysis: Transfer the Sample to a glass beaker, and dissolve in 100 mL of water and 10 mL of glacial acetic acid. Titrate with Titrant, and determine the endpoint potentiometrically. Each milliliter of Titrant is equivalent to 3.545 mg of chloride (Cl).
Acceptance criteria: 11.1%–11.9%
OPTICAL ROTATION 〈781S〉 , Procedures, Specific Rotation Sample solution: 125 mg/mL in methanol
Acceptance criteria: −0.7° to +0.7°
WATER DETERMINATION 〈921〉 , Method I: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed containers. Store at controlled room temperature.
Change to read:
USP REFERENCE STANDARDS 〈11〉
USP Sotalol Hydrochloride RS
USP Sotalol Related Compound A RS
N-[4-(Isopropylglycyl)phenyl]methanesulfonamide hydrochloride. C12H18N2O3S · HCl 306.81
USP Sotalol Related Compound B RS
N-(4-Formylphenyl)methanesulfonamide. C8H9NO3S 199.22
USP Sotalol Related Compound C RS
N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride. C12H30N2O3S · HCl 292.82 (CN 1-Aug-2024)

